title: Serum glucose and free fatty acids modulate growth hormone and luteinizing hormone secretion in the pig.
abstract: Two experiments were conducted to determine the effect of free fatty acids (FFA) and glucose treatment on growth hormone (GH) and luteinizing hormone secretion in the pig. In Experiment (Exp) 1, 15 prepuberal gilts received an intravenous infusion of FFA (n = 5; 3 ml of 10% Liposyn II/kg), glucose (n = 5; 1 g/kg), or saline (n = 5; 3 ml of 0.9%/kg). Jugular blood samples were collected every 15 min for 2 hr before and 3 hr after intravenous infusion of saline, FFA, and glucose. Synthetic [Ala15]-h growth hormone-releasing factor-(1-29)NH2 (1 microgram/kg) and gonadotropin-releasing hormone (0.2 micrograms/kg) were administered 30 min after infusion (Time 0 = infusion). In Exp 2, eight prepuberal gilts received either FFA (n = 4) or saline (n = 4) as described in Exp 1, except that treatments were given every hour ove a 10-hr period. Blood samples were collected every 15 min from 1 hr before to 10 hr after the start of FFA or saline infusion. In Exp 1, the peak GH response to growth hormone-releasing factor was delayed by 45 min (P less than 0.01) by glucose treatment and suppressed (P less than 0.01) by FFA treatment. The luteinizing hormone response to gonadotroph-releasing hormone was suppressed (P less than 0.03) by glucose and enhanced (P less than 0.03) by FFA. In Exp 2, the number of GH pulses was increased (P less than 0.05) by FFA infusion and GH concentrations were positively correlated (r = 0.58, P less than 0.0003) with FFA concentrations, while luteinizing hormone pulse amplitude was greater (P less than 0.01) in FFA gilts than in saline gilts. These results indicate that FFA are more effective modulators of GH secretion than acute hyperglycemia, while metabolic status can alter pituitary responsiveness to gonadotropin-releasing hormone.
authors.affiliation: Russell Research Center, USDA, ARS, Athens, Georgia 30613.
authors.forename: C R
authors.initials: CR
authors.lastname: Barb
authors.forename: R R
authors.initials: RR
authors.lastname: Kraeling
authors.forename: J B
authors.initials: JB
authors.lastname: Barrett
authors.forename: G B
authors.initials: GB
authors.lastname: Rampacek
authors.forename: R M
authors.initials: RM
authors.lastname: Campbell
authors.forename: T F
authors.initials: TF
authors.lastname: Mowles
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000502:physiology*; D005230:Fatty Acids, Nonesterified / Q000493:pharmacokinetics / Q000494:pharmacology*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology; D013006:Growth Hormone / Q000378:metabolism*; D013007:Growth Hormone-Releasing Hormone / Q000494:pharmacology; D007262:Infusions, Intravenous; D007986:Luteinizing Hormone / Q000378:metabolism*; D010902:Pituitary Gland / Q000187:drug effects* / Q000378:metabolism; D011673:Pulsatile Flow; D013552:Swine
chemical_list: D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007987:Gonadotropin-Releasing Hormone; D007986:Luteinizing Hormone; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone